PIRS - Total Utang marang Modal Pieris Pharma

Logo perusahaan publik Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals (PIRS) specializes in developing innovative protein anticalins to combat pulmonary and cancer pathologies. This price chart illustrates low capital expenditures driven by German R&D and US manufacturing outsourcing, with the indicator standing at 0.09. The company is currently undergoing a rigorous reorganization following the collapse of deals, seeking to find a buyer for its patents or merge with another player.

PIRS: Total Utang marang Modal Pieris Pharmaceuticals, Inc. 04.07.2022 - 30.10.2026

Rincian analitis perusahaan Pieris Pharmaceuticals

- rega lan prakiraan konsensus rega:
Bagan rega Pieris Pharmaceuticals, Inc.|PIRS - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Pieris Pharmaceuticals|PIRS - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Pieris Pharmaceuticals|PIRS - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku pieris.com|PIRS - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Pieris Pharmaceuticals|PIRS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Pieris Pharmaceuticals|PIRS - Gunggung utang perusahaan|Utang marang nilai buku Pieris Pharmaceuticals|PIRS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Pieris Pharmaceuticals|Indikator likuiditas cepet pieris.com
- informasi bathi lan kelipatan valuasi:
PIRS - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Pieris Pharmaceuticals, Inc.
Barang utama Pieris Pharma

For the biotech business of Pieris Pharmaceuticals (PIRS), which relies on licensing payments and partner royalties, maintaining a low debt-to-equity ratio is critical. By analyzing the leverage ratio—total debt to equity—an investor assesses the proportion of external financing within the asset structure, which determines the company's ability to survive periods without upfront payments without risking bankruptcy.

Analisis pesaing Pieris Pharmaceuticals

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Oramed Pharmaceuticals Inc. ORMP|ENTX (Entera Bio Ltd) - Utang Agregat marang Ekuitas|MindWalk - Total Utang marang Modal|Koefisien Total Utang marang Modal ABVC BioPharma, Inc ABVC|CPIX: Total Utang marang Modal|Utang marang Modal quantumbiopharma.com (QNTM)|Utang marang Ekuitas FibroGen|TELO: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal RANI|Koefisien Total Utang marang Modal synergychc.com|Utang marang Ekuitas Rallybio RLYB|Koefisien Total Utang marang Modal Lexaria Bioscience Corp (LEXX)|PULM: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PTHL (Pheton Holdings Ltd)|aptorumgroup.com (APM) - Utang marang Ekuitas|Utang Agregat marang Ekuitas LYRA (Lyra Therapeutics Inc)|IBO (Impact BioMedical Inc) - Total Utang marang Modal|TNFA: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal YCBD|Total Utang marang Modal PainReform Ltd (PRFX)|Utang marang Ekuitas Altamira Therapeutics Ltd. CYTO|Rasio Kabeh Utang marang Dana Pribadi LIPO|OPTN - Utang marang Ekuitas|procapsgroup.com (PROC) - Rasio Total Utang marang Ekuitas|PTPI: Total Utang marang Modal|Qilian International Holding Group (QLI) - Total Utang marang Modal|SLRN (ACELYRIN, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas TFF Pharmaceuticals, Inc (TFFP)